Monday , March 1 2021

Colombia and Ghana join together to create a new vaccine against malaria

In Ghana, between 30% and 40% of hospitalizations are due to malaria, so the government of the country has decided to support Dr. Patarroyo's work, said the former director of the Noguchi Memorial Institute for Medical Research in Ghana. Kwadwo A. Koram.

"We are trying to develop the vaccine for about 40 years, but with a totally different methodology, it does the chemical synthesis of the parasites that the parasite uses to invade red blood cells or liver cells," Patarroyo told Efe.

The Colombian scientist, who discovered the first malaria vaccine in 1987 and is a global reference to virus research, said that among the difficulties of developing the original "Colombian Falciparum Vaccine, Colfavac 90-100" of the molecules and their application in tests.

"It took us a long time to identify not only the molecules but also the parts, also to identify which ones were very important and besides, so that we could use them in monkeys so that when they were vaccinated (…) they would not develop the disease ".

Patarroyo, who runs Colombia's Foundation for the Inception of Colombia (FIDIC), said that Ghanaian co-operation resulted from a request from Colombian ambassador Claudia Turbay Quintero.

The initiative also includes the Universidad del Rosario Medical School in Bogota and the Tunja-based Boyacá University.

The Colombian immunologist, the Prince of Asturias Award for Scientific and Technical Research in 1994, assured that there is still no date for the official launch of the vaccine.

"There is always some extra inconvenience, as for example, we quit four years as a result of a series of loquizers who rushed them to say we had illegal protests with monkeys and cost us four years of closing the institute," he explained.

He also added that to date the malaria risks in Colombia are "relatively low", while in Ghana the percentages are "very high".

The Ghanaian government created an antivirus plan in 2014 to reduce deaths from this disease by as much as 75% by 2020.

Source link